Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
LOL. It's gonna go back over $6 in the states. I can't believe nobody is buying here in London. Or where ever they reside in the depths of cluelessness.
I've staggered several totaling 200K average 45-46. Let's see who wants to give theirs away to me. It's only gambling if you need to know where the free buffet is right?
Not a problem. I'll grab what i can with them. Doing some in depth digging here. With Z and H in charge now I'm 100% confident they were brought in to open the books and settle on a price for a suitor. My initial thought was a Euro company the likes of Astra or Sanofi or BI would easily swoop in and grab the company on the cheap, cheap; like $20-$25 per share. But the more I look at it I believe Vertex would have more to gain from the E application for CF.
We'll find out soon enough. And that would be after ALL of retail has sold and on to the next flavor of the day.
Over the weekend I went to the store and got one of those 1000 piece puzzles. You know, the kind that has pictures on BOTH sides and impossible to figure out? Well, those are pretty easy for some people. And in my puzzle there's this guy Zaccardelli and he joins Cempra as CEO. Together, with this guy Hahn, they ink a buyout for Cempra less than a year later. So, together they leave Cempra and they BOTH land over at Dova. Hahn goes in early to get inside the books. Zaccardelli comes in a few months later as CEO. And within a year now Dova is bought out. Now Zaccardelli and Hahn land over at Verona. Was Verona hiring? O course not. They are shopping a buyout and Zaccardelli and Hahn are there to bring it to conclusion.
This is a nice puzzle hanging on the wall. It's about to get a million visitors lining up to absorb its beauty.
And of course ALL of you missed the part where Hahn led the DOVA buyout. That was fun. I owned it actually when it broke out over $15 last Sept.
I see no reason why that doesn't happen for Verona. Let Morgan ink a partner in his one on ones tomorrow and Hahn can start shopping a suitor for the company if he hasn't started already.
Of course World Congress means nothing tomorrow. Right? Hey! You know what would be hilarious? If all the sheep bailed on VRP because of some change that is actually good for the company happened. Then they announced some news at World Congress that spikes it over 100p again. Now that would be amazingly hilarious because it keeps happening to hundreds of other biotech companies so why not this one? lmao
LOL. The drones over on Apple had virtually the identical reaction when Jobs departed this planet. The world as they knew it was over. No one had a clue what a Tim Cook was.
That was $500 Billion in market cap ago. PLEASE please kindly give me your cheap shares on Verona.
Not sure why everyone is insisting some slow burn out. Volume is down to nothing US and UK. Looking back at historicals this was the case before three dramatic spikes to the upside. Glass half full/glass half empty. Glass half full says huge money to be made on low volume weakness especially with 100+p again. Glass half empty says, "My life sucks seeing this price down here yet again."
It's showing on my end as up 5.46% before any shares trading. Are you used to it doing this before now? Obviously it doesn't mean much if the price is down here in the 50's instead over over 200 where it belongs.
It certainly would be nice if it did! I have not seen a break down of the Coronavirus or those suffering from its symptoms or those that have died. I'm not a medical professional, however, it would seem if Ensifentrine has both rescue and inti inflammatory properties it most certainly could be used in emergencies to bring about immediate quality of life relief.
I had to go back and look again about the price action on Nasdaq. After the spike on their recent trial results, it came down right away as if the news meant nothing. On the 14th it closed at $6.31. At the open the following morning, precisely the open, it spiked instantly to $6.83 as if it was some manufactured matching of the AIM VRP action already happening. Then it came straight down to spend 3 days in the $5's. As the AIM price began to move higher this week, VRNA followed suit moving back in to the $6's. Sure enough, Tues & Wed saw instant price spikes at the open to $6.75 and $6.91 that once again immediately failed. Now VRNA finds itself back in the $5's once again.
My point is there is a feigned attempt to keep it in line with AIM pricing but it would seem Nasdaq is leading this parade when it should be the bigger funds and $$ in the UK. Somebody needs to step up.
Another thing. I happened to be watching VRNA on Nasdaq yesterday apparently when that hit piece was published. The quick dip brought in a LOT of size buying, or should I sy covering their shorts. Yes, it was organized and paid by someone to get a short position covered. Makes me believe more good news is close at hand.
I brought up the question of who leads the market for ADRs and particularly VRP or VRNA. No one seems to know. But I will say this. Post the recent price run just this past week alone there's been a rather telling phenomenon in the US. On TWO separate occasions, when VRP was up in London, VRNA spiked precisely at the opening bell to $6.90 US. And then instantly down. It was as if to say it was price matching London, now let's get on with continuing to short this thing. And on BOTH occasions, that spike was met with a dip down in to the $5's where we are now. That to me indicates an organized liquidity game to gather shares for something larger to the upside.
As for Weiwei...she's a hack. It's a paid hatchet job. There's no way Wedbush and Suntrust would put out $60 and $34 targets back to back with Wedbush buying a large block if this article were anywhere close to true.
Hmmmm. Even more blocks today. Somebody taking advantage of the Arix stupidity.
LAST FIVE PUBLISHED TRADES
Time/date of execution Price Currency Volume Trade value* Trade type Trade flags MIC
15:48:36 22-Jan-2020 60.00 GBX 50,000 30,000.00 Off-book LRGS AIMX
15:48:45 22-Jan-2020 60.00 GBX 25,000 15,000.00 Off-book LRGS AIMX
15:56:39 22-Jan-2020 60.00 GBX 2,000 1,200.00 Off-book AIMX
15:37:44 22-Jan-2020 58.50 GBX 4,000 2,340.00 Off-book AIMX
15:27:13 22-Jan-2020 58.50 GBX 4,119 2,409.61 Off-book AIMX
Well, not to burst anyone's bubble but there are distinct characteristics associated with US biotech stocks not usually seen with any other sector. First, as you all know, US bios tend to get rewarded handsomely for successful trials, NDA's, FDA special designations. The market tends to price in FULL success of a drug approval by FDA and it's estimated sales in most respects. That's why when you see any bios gets FDA approval for a drug, there is rarely any fanfare, or it even goes lower because it was already priced for that milestone. As you also know, if a trial fails, or it shows any adverse events, the market punishes that stock severely. Usually it's in the 30%-90% range depending on whether they will back up and refile, or whether they will abandon the drug altogether.
The other important point here is financing. The bigger companies with $1-$10 bil market cap tend to go higher when financing is announced. The mindset is that the money will carry their best prospect through to FDA approval. However, when a low capitalization stock does financing, it usually gets manipulated downward severely by short sellers screaming dilution.
The last important thing to remember. Biotechs very rarely care whether the market is up or down like the market. The pattern for the past year as the US markets continue to keep setting new highs is the biotechs are down overall. When the market sees profit taking, traders tend to move over to oversold biotechs.
The US Futures are up substantially tonight. That is good if you're in to tech stocks.
Did you all take note of the last five published trades today?
Time/date of execution Price Currency Volume Trade value* Trade type Trade flags MIC
16:28:41 21-Jan-2020 60.00 GBX 25,000 15,000.00 Off-book LRGS AIMX
17:08:25 21-Jan-2020 58.00 GBX 6,500 3,770.00 Off-book XOFF
16:16:49 21-Jan-2020 60.00 GBX 2,500 1,500.00 Off-book AIMX
15:28:12 21-Jan-2020 60.00 GBX 10,000 6,000.00 Off-book AIMX
15:20:46 21-Jan-2020 59.80 GBX 1,852 1,107.50 Off-book AIMX
Yet it says the high of day was 58. Yup. Even more manipulation
it would appear somebody with some common sense woke up stateside. Up 16%. At least it's a start.
A couple of other biologic companies are soaring in the states today on being granted FDA Fast Track status while still in Phase 1 & early Phase 2. One even 300$ higher. I've been looking here for the same designation for Ensifentrine and cannot find anything. I will say this. Any drug therapy that provides a dual purpose and also provides quality of life is always approved by the FDA for Fast track and/or Breakthrough Therapy designations. Has JAK indicated anywhere that those applications have been made and are pending? And also, where does Ensifentrine stand on any special EMA designations? Thanks
+4.20. Like I said, big boy eyes are watching and they've had enough of the BS
OK. I get it. This is really just a ruse here and nobody knows wth is going on. Why no answers to my questions...and they are legitimate. One thing I did just come across though. Orbimed holds a large stake in VRP right behind Novo. They also came in large in the states on VRNA. Orbimed is also one of the largest holders of ADVM in the states. Not long ago ADVM broke out on WetMD data up above $15. Then, follow on data was released in the $12's on the same data that was "misinterpreted" and that took it down to the $4.90's. Next thing you know it is right back over $12. My point is it all appears to have been orchestrated and Orbimed cashed huge. I have the distinct feeling Orbimed is very active behind the scenes and couldn't give a flip what Arix/Arthurian does. They are extremely small & laughable fish in the grand scheme of things. I wouldn't be surprised to see Orbimed pull the same exact reversal and run up on VRP/VRNA. IMO they now control both sides of a stocked pond.